Reglődi D - Search Results

1

Examination of PACAP38-like immunoreactivity in different milk and infant formula samples.

Csanaky K, Reglődi D, Bánki E, Tarcai I, Márk L, Helyes Z, Ertl T, Gyarmati J, Horváth K, Sántik L, Tamás A. Csanaky K, et al. Among authors: reglodi d. Acta Physiol Hung. 2013 Mar;100(1):28-36. doi: 10.1556/APhysiol.100.2013.1.2. Acta Physiol Hung. 2013. PMID: 23471040

2

Pituitary adenylate cyclase activating polypeptide is highly abundant in the nervous system of anoxia-tolerant turtle, Pseudemys scripta elegans.

Reglödi D, Somogyvári-Vigh A, Vígh J, Li M, Lengvári I, Arimura A. Reglödi D, et al. Peptides. 2001 Jun;22(6):873-8. doi: 10.1016/s0196-9781(01)00412-0. Peptides. 2001. PMID: 11390016

3

Distribution and daily variations of PACAP in the chicken brain.

Józsa R, Somogyvári-Vigh A, Reglödi D, Hollósy T, Arimura A. Józsa R, et al. Among authors: reglodi d. Peptides. 2001 Sep;22(9):1371-7. doi: 10.1016/s0196-9781(01)00477-6. Peptides. 2001. PMID: 11514017

4

Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats.

Tamás A, Reglõdi D, Szántó Z, Borsiczky B, Németh J, Lengvári I. Tamás A, et al. Among authors: reglodi d. Neuro Endocrinol Lett. 2002 Jun;23(3):249-54. Neuro Endocrinol Lett. 2002. PMID: 12080287

5

Comparative distribution of VIP in the central nervous system of various species measured by a new radioimmunoassay.

Németh J, Jakab B, Reglodi D, Lubics A, Józsa R, Hollósy T, Tamás A, Lengvári I, Görcs T, Szolcsányi J. Németh J, et al. Among authors: reglodi d. Regul Pept. 2002 Nov 15;109(1-3):3-7. doi: 10.1016/s0167-0115(02)00165-9. Regul Pept. 2002. PMID: 12409208

6

PACAP inhibits anoxia-induced changes in physiological responses in horizontal cells in the turtle retina.

Rábl K, Reglodi D, Bánvölgyi T, Somogyvári-Vigh A, Lengvári I, Gábriel R, Arimura A. Rábl K, et al. Among authors: reglodi d. Regul Pept. 2002 Nov 15;109(1-3):71-4. doi: 10.1016/s0167-0115(02)00189-1. Regul Pept. 2002. PMID: 12409217

7

Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia.

Reglodi D, Tamás A, Somogyvári-Vigh A, Szántó Z, Kertes E, Lénárd L, Arimura A, Lengvári I. Reglodi D, et al. Peptides. 2002 Dec;23(12):2227-34. doi: 10.1016/s0196-9781(02)00262-0. Peptides. 2002. PMID: 12535703

8

Examination of sensorimotor performance following middle cerebral artery occlusion in rats.

Reglodi D, Tamás A, Lengvári I. Reglodi D, et al. Brain Res Bull. 2003 Feb 15;59(6):459-66. doi: 10.1016/s0361-9230(02)00962-0. Brain Res Bull. 2003. PMID: 12576143

9

The effects of PACAP and PACAP antagonist on the neurobehavioral development of newborn rats.

Reglodi D, Kiss P, Tamás A, Lengvári I. Reglodi D, et al. Behav Brain Res. 2003 Mar 18;140(1-2):131-9. doi: 10.1016/s0166-4328(02)00289-9. Behav Brain Res. 2003. PMID: 12644286

10

Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.

Reglodi D, Lubics A, Tamás A, Szalontay L, Lengvári I. Reglodi D, et al. Behav Brain Res. 2004 May 5;151(1-2):303-12. doi: 10.1016/j.bbr.2003.09.007. Behav Brain Res. 2004. PMID: 15084446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters